A Phase II Study of Depsipeptide (NSC-630176) [romidepsin] In Patients With Advanced Transitional Cell Carcinoma Of The Urinary Tract Who Have Progressed After Receiving One Prior Chemotherapy Regimen For Advanced Disease

Trial Profile

A Phase II Study of Depsipeptide (NSC-630176) [romidepsin] In Patients With Advanced Transitional Cell Carcinoma Of The Urinary Tract Who Have Progressed After Receiving One Prior Chemotherapy Regimen For Advanced Disease

Discontinued
Phase of Trial: Phase II

Latest Information Update: 01 Nov 2012

At a glance

  • Drugs Romidepsin (Primary)
  • Indications Bladder cancer; Urogenital cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Jun 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 24 Aug 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top